All Articles

As the FDA targets nicotine, a new patent for unique hemp-tobacco vape pods positions Cabbacis to disrupt the growing harm-reduction market.

AI is here, but schools are divided. A new national initiative offers leaders a roadmap to move beyond reactive policies and intentionally shape learning.

Investors eye Great-West Lifeco's Q4 results on Feb. 11, anticipating if the financial giant can sustain its record-breaking momentum from Q3 2025.

A new partnership embeds Todata's AI-powered SiteGrades platform into CRIO's eSource system, offering research sites real-time operational intelligence.

December saw a price dip, but 2025 brought more homes to market and slower price growth, signaling a major shift for both buyers and sellers in PA.

A new grant funds a nationwide expansion of a program proven to help students evaluate sources, resist bias, and make better decisions in a digital world.

A new on-site vet clinic aims to improve dog health, reduce wait times, and accelerate the pairing of life-saving service dogs with military veterans.

The digital cognitive health firm's HITRUST i1 certification validates its commitment to protecting sensitive patient data in an era of rising cyber threats.

As New Jersey faces a critical shortage of 24,000+ nurses, a local talent platform bets on specialized expertise to solve a crisis national firms can't fix.

With a fresh $10M, Furl is unleashing agentic AI to autonomously fix the vulnerabilities that overburdened security and IT teams can only find.

With two major trial results looming, Zura Bio appoints Sandeep Kulkarni, who led Tourmaline to a Novartis sale, to navigate its high-stakes future.

Ad data giant Guideline appoints a new CPO, SVP of Data, and SVP of Sales, betting on seasoned leadership to dominate the AI-driven marketing landscape.

Nan McKay & Associates' renewed IACET accreditation signals a commitment to high standards as housing pros face complex new HUD rules like NSPIRE and HOTMA.

Global IT provider Sycomp partners with IBM's Cloudability to launch enhanced services, giving enterprises powerful new tools to control cloud costs.

An investigational drug from Veloxis Pharmaceuticals has received a key FDA designation, offering new hope for liver transplant patients facing lifelong toxic therapies.

A new report finds 83% of consumers can spot AI videos, and for many, it erodes brand trust. How can marketers navigate the AI authenticity gap?

The hydraulic hose franchise shattered records in 2025, revealing deep demand for recession-resistant B2B businesses that keep America's industries running.

As Cellebrite prepares to report its 2025 results, all eyes are on its performance as a key indicator for the future of AI in law enforcement and public safety.

Brands are ditching costly ads for immersive, creator-led events. See how Gallery Club House is rewriting the rules for Big Game marketing in 2026.

With AWS's Mark Relph joining its AI Council, Qlik reinforces its strategy to move enterprise AI from experimentation to governed, real-world application.